Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 640

1.

Association between changes in the mRNA expression of platelet-activating factor receptor in peripheral blood mononuclear cells and progression of diabetic nephropathy.

Ghavidel Darestani S, Kurano M, Shinnakasu A, Yamamoto K, Dochi Y, Uemura K, Ikeda Y, Arimura A, Arimura H, Kikuchi A, Hashiguchi H, Deguchi T, Nishio Y.

Diabetol Int. 2019 Apr 11;11(1):11-18. doi: 10.1007/s13340-019-00394-w. eCollection 2020 Jan.

PMID:
31949999
2.

A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer.

Macpherson IR, Spiliopoulou P, Rafii S, Saggese M, Baird RD, Garcia-Corbacho J, Italiano A, Bonneterre J, Campone M, Cresti N, Posner J, Takeda Y, Arimura A, Spicer J.

Breast Cancer Res. 2019 Dec 31;22(1):1. doi: 10.1186/s13058-019-1178-0.

3.

Eruptive squamous cell carcinoma in a patient treated with concomitant pembrolizumab and imiquimod.

Kanekura T, Arimura A, Kirishima M, Tanimoto A.

J Dermatol. 2019 Dec;46(12):1202-1204. doi: 10.1111/1346-8138.15101. Epub 2019 Oct 9.

PMID:
31599020
4.

Effects of glycemic control and hypoglycemia on Thrombus formation assessed using automated microchip flow chamber system: an exploratory observational study.

Yamamoto K, Ito T, Nagasato T, Shinnakasu A, Kurano M, Arimura A, Arimura H, Hashiguchi H, Deguchi T, Maruyama I, Nishio Y.

Thromb J. 2019 Sep 2;17:17. doi: 10.1186/s12959-019-0206-8. eCollection 2019.

5.

Granulomatous/sarcoid-like reactions in the setting of programmed cell death-1 inhibition: a potential mimic of disease recurrence.

Hiraki T, Hatanaka M, Arimura A, Kawahira H, Kirishima M, Kitazono I, Horinouchi M, Higashi M, Kanekura T, Tanimoto A.

J Cutan Pathol. 2020 Feb;47(2):154-160. doi: 10.1111/cup.13569. Epub 2019 Sep 1.

PMID:
31437317
6.

Cutaneous microangiopathy in patients with type 2 diabetes: Impaired vascular endothelial growth factor expression and its correlation with neuropathy, retinopathy and nephropathy.

Sugimoto K, Murakami H, Deguchi T, Arimura A, Daimon M, Suzuki S, Shimbo T, Yagihashi S.

J Diabetes Investig. 2019 Sep;10(5):1318-1331. doi: 10.1111/jdi.13020. Epub 2019 Apr 2.

7.

An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours.

Arkenau HT, Italiano A, Mak G, Toulmonde M, Baird RD, Garcia-Corbacho J, Plummer R, Flynn M, Forster M, Wilson RH, Tosi D, Adenis A, Donaldson K, Posner J, Kawabata I, Arimura A, Deva S, Spicer J.

Eur J Cancer. 2018 Nov;103:17-23. doi: 10.1016/j.ejca.2018.07.134. Epub 2018 Sep 6.

PMID:
30196106
8.

Hypohidrotic ectodermal dysplasia with strabismus.

Okubo A, Fujii K, Arimura A, Katsue H, Higashi Y, Shimomura Y, Kanekura T.

J Dermatol. 2018 Jul;45(7):e191-e192. doi: 10.1111/1346-8138.14252. Epub 2018 Mar 24. No abstract available.

PMID:
29573265
9.

Granulocyte and monocyte adsorption apheresis for palmoplantar pustulosis with extra-palmoplantar lesions and pustulotic arthro-osteitis.

Arimura A, Fujii K, Ibusuki A, Hatanaka M, Sakanoue M, Higashi Y, Kanekura T.

J Dermatol. 2018 Jun;45(6):e167-e168. doi: 10.1111/1346-8138.14191. Epub 2017 Dec 21. No abstract available.

PMID:
29266440
10.

Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy.

Masuda T, Ueda M, Suenaga G, Misumi Y, Tasaki M, Izaki A, Yanagisawa Y, Inoue Y, Motokawa H, Matsumoto S, Mizukami M, Arimura A, Deguchi T, Nishio Y, Yamashita T, Inomata Y, Obayashi K, Ando Y.

Neurology. 2017 Jun 6;88(23):2192-2197. doi: 10.1212/WNL.0000000000004016. Epub 2017 May 10.

PMID:
28490654
11.

The Combination Therapy of Fenofibrate and Ezetimibe Improved Lipid Profile and Vascular Function Compared with Statins in Patients with Type 2 Diabetes.

Shinnakasu A, Yamamoto K, Kurano M, Arimura H, Arimura A, Kikuti A, Hashiguchi H, Deguchi T, Nishio Y.

J Atheroscler Thromb. 2017 Jul 1;24(7):735-748. doi: 10.5551/jat.39446. Epub 2017 Apr 27.

12.

The Inhibitory Effect of S-777469, a Cannabinoid Type 2 Receptor Agonist, on Skin Inflammation in Mice.

Haruna T, Soga M, Morioka Y, Imura K, Furue Y, Yamamoto M, Hayakawa J, Deguchi M, Arimura A, Yasui K.

Pharmacology. 2017;99(5-6):259-267. doi: 10.1159/000455916. Epub 2017 Feb 18.

PMID:
28214870
13.

A phase I/II study of cancer peptide vaccine S-288310 in patients with advanced urothelial carcinoma of the bladder.

Obara W, Eto M, Mimata H, Kohri K, Mitsuhata N, Miura I, Shuin T, Miki T, Koie T, Fujimoto H, Minami K, Enomoto Y, Nasu T, Yoshida T, Fuse H, Hara I, Kawaguchi K, Arimura A, Fujioka T.

Ann Oncol. 2017 Apr 1;28(4):798-803. doi: 10.1093/annonc/mdw675.

14.

Usefulness of three-dimensional transesophageal echocardiography for diagnosis of hemolytic anemia due to inverted internal felt strip after surgery for aortic dissection.

Oda T, Yasunaga H, Zaima Y, Arimura A, Imai S, Kanamoto R, Fukuda H, Nakamura E, Tashiro H, Aoyagi S.

J Med Ultrason (2001). 2017 Apr;44(2):211-214. doi: 10.1007/s10396-016-0759-0. Epub 2016 Nov 17.

PMID:
27858229
15.

Investigation of the clinical significance of the growth hormone-releasing peptide-2 test for the diagnosis of secondary adrenal failure.

Arimura H, Hashiguchi H, Yamamoto K, Shinnakasu A, Arimura A, Kikuchi A, Deguchi T, Habu M, Fujio S, Arita K, Nishio Y.

Endocr J. 2016 Jun 30;63(6):533-44. doi: 10.1507/endocrj.EJ15-0587. Epub 2016 Mar 26.

16.

Psoriasis with verrucous appearance.

Baba A, Fujii K, Arimura A, Tada K, Higashi Y, Matsushita S, Kanekura T.

Int J Dermatol. 2016 Jul;55(7):e419-21. doi: 10.1111/ijd.13243. Epub 2016 Feb 15. No abstract available.

PMID:
26876922
17.

Effect of the potent and selective DP1 receptor antagonist, asapiprant (S-555739), in animal models of allergic rhinitis and allergic asthma.

Takahashi G, Asanuma F, Suzuki N, Hattori M, Sakamoto S, Kugimiya A, Tomita Y, Kuwajima G, Abraham WM, Deguchi M, Arimura A, Shichijo M.

Eur J Pharmacol. 2015 Oct 15;765:15-23. doi: 10.1016/j.ejphar.2015.08.003. Epub 2015 Aug 12.

PMID:
26277322
18.

S-777469, a novel cannabinoid type 2 receptor agonist, suppresses itch-associated scratching behavior in rodents through inhibition of itch signal transmission.

Haruna T, Soga M, Morioka Y, Hikita I, Imura K, Furue Y, Yamamoto M, Imura C, Ikeda M, Yamauchi A, Deguchi M, Shichijo M, Arimura A, Yasui K.

Pharmacology. 2015;95(1-2):95-103.

PMID:
25721168
19.

Granulocyte and monocyte adsorption apheresis for paradoxical reaction to infliximab.

Arimura A, Hatanaka M, Katsue H, Matsushita S, Kanekura T.

J Dermatol. 2015 Apr;42(4):438-9. doi: 10.1111/1346-8138.12789. Epub 2015 Feb 6. No abstract available.

PMID:
25655018
20.

Median neuropathy at the wrist as an early manifestation of diabetic neuropathy.

Horinouchi S, Deguchi T, Arimura K, Arimura A, Dochi Y, Uto T, Nakamura T, Arimura Y, Nishio Y, Takashima H.

J Diabetes Investig. 2014 Nov;5(6):709-13. doi: 10.1111/jdi.12211. Epub 2014 Mar 28.

21.

Intraepidermal nerve fiber density and nerve conduction study parameters correlate with clinical staging of diabetic polyneuropathy.

Arimura A, Deguchi T, Sugimoto K, Uto T, Nakamura T, Arimura Y, Arimura K, Yagihashi S, Nishio Y, Takashima H.

Diabetes Res Clin Pract. 2013 Jan;99(1):24-9. doi: 10.1016/j.diabres.2012.09.026. Epub 2012 Sep 21.

PMID:
23006635
22.

Discovery of S-777469: an orally available CB2 agonist as an antipruritic agent.

Odan M, Ishizuka N, Hiramatsu Y, Inagaki M, Hashizume H, Fujii Y, Mitsumori S, Morioka Y, Soga M, Deguchi M, Yasui K, Arimura A.

Bioorg Med Chem Lett. 2012 Apr 15;22(8):2803-6. doi: 10.1016/j.bmcl.2012.02.072. Epub 2012 Mar 3.

PMID:
22444677
23.

CB 1/2 dual agonists with 3-carbamoyl 2-pyridone derivatives as antipruritics: reduction of CNS side effects by introducing polar functional groups.

Odan M, Ishizuka N, Hiramatsu Y, Inagaki M, Hashizume H, Fujii Y, Mitsumori S, Morioka Y, Soga M, Deguchi M, Yasui K, Arimura A.

Bioorg Med Chem Lett. 2012 Apr 15;22(8):2894-7. doi: 10.1016/j.bmcl.2012.02.054. Epub 2012 Mar 3.

PMID:
22437111
24.

Discovery of S-444823, a potent CB1/CB2 dual agonist as an antipruritic agent.

Odan M, Ishizuka N, Hiramatsu Y, Inagaki M, Hashizume H, Fujii Y, Mitsumori S, Morioka Y, Soga M, Deguchi M, Yasui K, Arimura A.

Bioorg Med Chem Lett. 2012 Apr 15;22(8):2898-901. doi: 10.1016/j.bmcl.2012.02.050. Epub 2012 Feb 23.

PMID:
22421019
25.

Prostanoid DP receptor antagonists suppress symptomatic asthma-like manifestation by distinct actions from a glucocorticoid in rats.

Hirano Y, Shichijo M, Ikeda M, Kitaura M, Tsuchida J, Asanuma F, Yanagimoto T, Furue Y, Imura K, Yasui K, Arimura A.

Eur J Pharmacol. 2011 Sep;666(1-3):233-41. doi: 10.1016/j.ejphar.2011.05.003. Epub 2011 May 11.

PMID:
21596028
26.

A prostaglandin D2 receptor antagonist modifies experimental asthma in sheep.

Shichijo M, Arimura A, Hirano Y, Yasui K, Suzuki N, Deguchi M, Abraham WM.

Clin Exp Allergy. 2009 Sep;39(9):1404-14. doi: 10.1111/j.1365-2222.2009.03275.x. Epub 2009 May 26.

PMID:
19486034
27.

Antitumor efficacy of recombinant human interleukin-2 combined with sorafenib against mouse renal cell carcinoma.

Iguchi M, Matsumoto M, Hojo K, Wada T, Matsuo Y, Arimura A, Abe K.

Jpn J Clin Oncol. 2009 May;39(5):303-9. doi: 10.1093/jjco/hyp021. Epub 2009 Mar 31.

PMID:
19336449
28.

Association of T-cell receptor Vbeta haplotypes with dry skin in DS-Nh mice.

Imura K, Yoshioka T, Hikita I, Hirasawa T, Sakata T, Matsutani T, Horikawa T, Arimura A.

Clin Exp Dermatol. 2009 Jan;34(1):61-7. doi: 10.1111/j.1365-2230.2008.02921.x.

PMID:
19018787
29.

Contribution of itch-associated scratch behavior to the development of skin lesions in Dermatophagoides farinae-induced dermatitis model in NC/Nga mice.

Yamamoto M, Haruna T, Ueda C, Asano Y, Takahashi H, Iduhara M, Takaki S, Yasui K, Matsuo Y, Arimura A.

Arch Dermatol Res. 2009 Oct;301(10):739-46. doi: 10.1007/s00403-008-0912-8. Epub 2008 Nov 1.

PMID:
18979107
30.

Suppression of immunoglobulin production by a novel dihydroorotate dehydrogenase inhibitor, S-2678.

Deguchi M, Kishino J, Hattori M, Furue Y, Yamamoto M, Mochizuki I, Iguchi M, Hirano Y, Hojou K, Nagira M, Nishitani Y, Okazaki K, Yasui K, Arimura A.

Eur J Pharmacol. 2008 Dec 28;601(1-3):163-70. doi: 10.1016/j.ejphar.2008.09.010. Epub 2008 Sep 20.

PMID:
18834876
31.

Impact of the Gly573Ser substitution in TRPV3 on the development of allergic and pruritic dermatitis in mice.

Yoshioka T, Imura K, Asakawa M, Suzuki M, Oshima I, Hirasawa T, Sakata T, Horikawa T, Arimura A.

J Invest Dermatol. 2009 Mar;129(3):714-22. doi: 10.1038/jid.2008.245. Epub 2008 Aug 28.

32.

The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.

Nogami W, Yoshida H, Koizumi K, Yamada H, Abe K, Arimura A, Yamane N, Takahashi K, Yamane A, Oda A, Tanaka Y, Takemoto H, Ohnishi Y, Ikeda Y, Miyakawa Y.

Haematologica. 2008 Oct;93(10):1495-504. doi: 10.3324/haematol.12752. Epub 2008 Aug 25.

33.

Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.

Oku H, Shimizu T, Kawabata T, Nagira M, Hikita I, Ueyama A, Matsushima S, Torii M, Arimura A.

Eur J Pharmacol. 2008 Aug 20;590(1-3):400-8. doi: 10.1016/j.ejphar.2008.06.046. Epub 2008 Jun 16.

PMID:
18598692
34.

Inhibitory effect of a potent and selective cytosolic phospholipase A2alpha inhibitor RSC-3388 on skin inflammation in mice.

Yamamoto M, Haruna T, Imura K, Hikita I, Furue Y, Higashino K, Gahara Y, Deguchi M, Yasui K, Arimura A.

Pharmacology. 2008;81(4):301-11. doi: 10.1159/000117816. Epub 2008 Feb 21.

PMID:
18287786
35.

Renoprotection by pituitary adenylate cyclase-activating polypeptide in multiple myeloma and other kidney diseases.

Li M, Maderdrut JL, Lertora JJ, Arimura A, Batuman V.

Regul Pept. 2008 Jan 10;145(1-3):24-32. Epub 2007 Sep 18. Review.

PMID:
17935800
36.

Contribution of prostaglandin D2 via prostanoid DP receptor to nasal hyperresponsiveness in guinea pigs repeatedly exposed to antigen.

Yasui K, Asanuma F, Hirano Y, Shichijo M, Deguchi M, Arimura A.

Eur J Pharmacol. 2008 Jan 14;578(2-3):286-91. Epub 2007 Oct 24.

PMID:
17927976
37.

Influence of TRPV3 mutation on hair growth cycle in mice.

Imura K, Yoshioka T, Hikita I, Tsukahara K, Hirasawa T, Higashino K, Gahara Y, Arimura A, Sakata T.

Biochem Biophys Res Commun. 2007 Nov 23;363(3):479-83. Epub 2007 Sep 6.

PMID:
17888882
38.

PACAP: the road to discovery.

Arimura A.

Peptides. 2007 Sep;28(9):1617-9. Epub 2007 Jun 12. No abstract available.

PMID:
17719697
39.

A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice.

Yamamoto M, Haruna T, Yasui K, Takahashi H, Iduhara M, Takaki S, Deguchi M, Arimura A.

Allergol Int. 2007 Jun;56(2):139-48. Epub 2007 May 1.

40.
41.

Synergistic effect of PGD2 via prostanoid DP receptor on TNF-alpha-induced production of MCP-1 and IL-8 in human monocytic THP-1 cells.

Hirano Y, Shichijo M, Deguchi M, Nagira M, Suzuki N, Nishitani Y, Hattori M, Arimura A.

Eur J Pharmacol. 2007 Mar 29;560(1):81-8. Epub 2007 Jan 20.

PMID:
17307163
42.

Pituitary adenylate cyclase-activating polypeptide-induced differentiation of embryonic neural stem cells into astrocytes is mediated via the beta isoform of protein kinase C.

Watanabe J, Ohba M, Ohno F, Kikuyama S, Nakamura M, Nakaya K, Arimura A, Shioda S, Nakajo S.

J Neurosci Res. 2006 Dec;84(8):1645-55.

PMID:
17022039
43.
44.

Changes in PACAP levels in the central nervous system after ovariectomy and castration.

Nemeth J, Tamas A, Jozsa R, Horvath JE, Jakab B, Lengvari I, Arimura A, Lubics A, Reglódi D.

Ann N Y Acad Sci. 2006 Jul;1070:468-73.

PMID:
16888211
45.

Comparative anatomy of PACAP-immunoreactive structures in the ventral nerve cord ganglia of lumbricid oligochaetes.

Molnar L, Pollak E, Boros A, Reglödi D, Tamás A, Lengvari I, Arimura A, Lubics A.

Ann N Y Acad Sci. 2006 Jul;1070:427-30.

PMID:
16888204
46.

Short-term fasting differentially alters PACAP and VIP levels in the brains of rat and chicken.

Jozsa R, Nemeth J, Tamas A, Hollosy T, Lubics A, Jakab B, Olah A, Lengvari I, Arimura A, Reglödi D.

Ann N Y Acad Sci. 2006 Jul;1070:354-8.

PMID:
16888191
47.

Presence of PACAP and VIP in embryonic chicken brain.

Jozsa R, Hollosy T, Nemeth J, Tamás A, Lubics A, Jakab B, Olah A, Arimura A, Reglödi D.

Ann N Y Acad Sci. 2006 Jul;1070:348-53.

PMID:
16888190
48.

Treatment of renal failure associated with multiple myeloma and other diseases by PACAP-38.

Arimura A, Li M, Batuman V.

Ann N Y Acad Sci. 2006 Jul;1070:1-4.

PMID:
16888145
49.

Association of a mutation in TRPV3 with defective hair growth in rodents.

Asakawa M, Yoshioka T, Matsutani T, Hikita I, Suzuki M, Oshima I, Tsukahara K, Arimura A, Horikawa T, Hirasawa T, Sakata T.

J Invest Dermatol. 2006 Dec;126(12):2664-72. Epub 2006 Jul 20.

50.

Spontaneous scratching behaviour in DS-Nh mice as a possible model for pruritus in atopic dermatitis.

Yoshioka T, Hikita I, Asakawa M, Hirasawa T, Deguchi M, Matsutani T, Oku H, Horikawa T, Arimura A.

Immunology. 2006 Jul;118(3):293-301.

Supplemental Content

Loading ...
Support Center